ACET - Aceto Corporation
| Previous Close | 11.17 |
| Open | 11.17 |
| Bid | 8.98 x 100 |
| Ask | 12.80 x 100 |
| Day's Range | 10.99 - 11.23 |
| 52 Week Range | 10.27 - 22.46 |
| Volume | 248,427 |
| Avg. Volume | 344,090 |
| Market Cap | 333.61M |
| Beta | 1.23 |
| PE Ratio (TTM) | 31.66 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 0.26 (2.33%) |
| Ex-Dividend Date | 2017-09-07 |
| 1y Target Est | N/A |
- Capital Cube•15 days ago
ETFs with exposure to Aceto Corp. : October 3, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Aceto Corp. Here are 5 ETFs with the largest exposure to ACET-US. Comparing the performance and risk of Aceto Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube•21 days agoAceto Corp. : ACET-US: Dividend Analysis : September 08th, 2017 (record date) : By the numbers : September 27, 2017
Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing Aceto Corp. with the following peers – Cambrex Corporation, Innophos Holdings, Inc., Quaker Chemical Corporation, Valeant Pharmaceuticals International Inc, Pfizer Inc., Merck & Co., Inc., Teligent, Inc., Mylan N.V., Novartis AG Sponsored ADR and Teva Pharmaceutical Industries Limited Sponsored ADR (CBM-US, IPHS-US, KWR-US, VRX-US, PFE-US, ... Read more (Read more...)
- Capital Cube•2 months ago
ETFs with exposure to Aceto Corp. : September 1, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Aceto Corp. Here are 5 ETFs with the largest exposure to ACET-US. Comparing the performance and risk of Aceto Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
- Zacks•2 months ago
Weakness Seen in Aceto Corporation (ACET) Estimates: Should You Stay Away?
Aceto Corporation (ACET) has witnessed a significant price decline in the past four weeks, and has seen negative earnings estimate revisions for the current quarter and year.
Capital Cube•2 months agoAceto Corp. :ACET-US: Earnings Analysis: Q4, 2017 By the Numbers : August 29, 2017
Categories: Yahoo FinanceGet free summary analysis Aceto Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Aceto Corp. – Cambrex Corporation, Innophos Holdings, Inc., Quaker Chemical Corporation, Valeant Pharmaceuticals International Inc, Pfizer Inc., Merck & Co., Inc., Novartis AG Sponsored ADR, Teva Pharmaceutical Industries Limited ... Read more (Read more...)
- Capital Cube•2 months ago
Aceto Corp. breached its 50 day moving average in a Bearish Manner : ACET-US : August 28, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Aceto Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of ACET earnings conference call or presentation 25-Aug-17 1:00pm GMT
Q4 2017 Aceto Corp Earnings Call
- Associated Press•2 months ago
Aceto posts 4Q profit
On a per-share basis, the Port Washington, New York-based company said it had profit of 6 cents. Earnings, adjusted for one-time gains and costs, were 27 cents per share. The chemical company posted revenue ...
- Zacks•2 months ago
Zacks.com featured highlights: AppFolio, Columbus McKinnon, Concert Pharmaceuticals, Aceto and Liberty Media
Zacks.com featured highlights: AppFolio, Columbus McKinnon, Concert Pharmaceuticals, Aceto and Liberty Media
- Zacks•2 months ago
5 Stocks to Bet on New Analyst Coverage
Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.
- Capital Cube•4 months ago
ETFs with exposure to Aceto Corp. : June 15, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Aceto Corp. Here are 5 ETFs with the largest exposure to ACET-US. Comparing the performance and risk of Aceto Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube•4 months agoAceto Corp. breached its 50 day moving average in a Bullish Manner : ACET-US : June 12, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Aceto Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)
Capital Cube•4 months agoAceto Corp. : ACET-US: Dividend Analysis : June 09th, 2017 (record date) : By the numbers : June 8, 2017
Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing Aceto Corp. with the following peers – Cambrex Corporation, Innophos Holdings, Inc., Quaker Chemical Corporation, Valeant Pharmaceuticals International Inc, Pfizer Inc., Merck & Co., Inc., Novartis AG Sponsored ADR, Teva Pharmaceutical Industries Limited Sponsored ADR, Mylan N.V. and Albany Molecular Research, Inc. (CBM-US, IPHS-US, KWR-US, ... Read more (Read more...)
- Capital Cube•5 months ago
ETFs with exposure to Aceto Corp. : June 2, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Aceto Corp. Here are 5 ETFs with the largest exposure to ACET-US. Comparing the performance and risk of Aceto Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube•5 months agoAceto Corp. :ACET-US: Earnings Analysis: Q3, 2017 By the Numbers : May 22, 2017
Categories: Yahoo FinanceGet free summary analysis Aceto Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Aceto Corp. – Cambrex Corporation, Innophos Holdings, Inc., Quaker Chemical Corporation, Valeant Pharmaceuticals International Inc, Pfizer Inc., Merck & Co., Inc., Novartis AG Sponsored ADR, Teva Pharmaceutical Industries Limited ... Read more (Read more...)
- Thomson Reuters StreetEvents•5 months ago
Edited Transcript of ACET earnings conference call or presentation 5-May-17 1:00pm GMT
Q3 2017 Aceto Corp Earnings Call
Capital Cube•5 months agoAceto Corp. breached its 50 day moving average in a Bearish Manner : ACET-US : May 8, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Aceto Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
- Associated Press•5 months ago
Aceto posts 3Q profit
On a per-share basis, the Port Washington, New York-based company said it had profit of 16 cents. Earnings, adjusted for non-recurring costs, were 39 cents per share. The chemical company posted revenue ...
- Capital Cube•6 months ago
Aceto Corp. – Value Analysis (NASDAQ:ACET) : April 24, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Aceto Corp. a score of 41. Our analysis is based on comparing Aceto Corp. with the following peers – Cambrex Corporation, Innophos Holdings, Inc., Quaker Chemical Corporation, Valeant Pharmaceuticals International Inc, Pfizer Inc., Merck & Co., Inc., Novartis AG Sponsored ADR, Teva Pharmaceutical Industries Limited Sponsored ADR, ... Read more (Read more...)
Capital Cube•6 months agoAceto Corp. breached its 50 day moving average in a Bullish Manner : ACET-US : April 21, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Aceto Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
- Yahoo Finance•6 months ago
Democrats found a way to speak Trump's language in pharma debate
The members of congress introduced a bill related to the talk last week. A quartet of Democratic members of Congress introduced a bill last week in harmony with President Donald Trump’s campaign promises of lowering prescription drug costs. Entitled the Improving Access to Affordable Prescription Drugs Act, the 128-page bill aims to overhaul what many view as a broken system that has seen bipartisan outrage over skyrocketing prices.
Capital Cube•7 months agoAceto Corp. : ACET-US: Dividend Analysis : March 10th, 2017 (record date) : By the numbers : April 3, 2017
Categories: Yahoo Finance Get free summary analysis Our analysis is based on comparing Aceto Corp. with the following peers – Cambrex Corporation, Innophos Holdings, Inc., Quaker Chemical Corporation, Valeant Pharmaceuticals International Inc, Pfizer Inc., Merck & Co., Inc., Teligent, Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Mylan N.V. and Albany Molecular Research, Inc. (CBM-US, IPHS-US, KWR-US, VRX-US, PFE-US, ... Read more (Read more...)
Zacks•7 months agoShould You Get Rid of INC Research (INCR) Now?
INC Research (INCR) should not be considered as it holds an unfavorable Zacks Rank and it has seen negative earnings estimate revisions.
Zacks•7 months agoTop Ranked Value Stocks to Buy for March 6th
Top Ranked Value Stocks to Buy for March 6th
Zacks•8 months agoShould You Get Rid of Ensign Group (ENSG) Now?
Ensign Group (ENSG) should not be considered as it holds an unfavorable Zacks Rank and it has seen negative earnings estimate revisions.
